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SUMMARY 
Objective: The diagnostic value of the transbronchial/transtracheal fine needle aspiration 
(TBFNA) cytology in the patients with mediastinal and/or hilar lymphadenopathy has been 
investigated.  
Method: Out of 116 patients with mediastinal/hilar lymphadenopathy, the diagnosis of 
sarcoidosis was established in 88 (75,9%). One hundred and seventi-one TBFNAs with 
cytological 26-gauge needle were performed, from different lymph node stations. Adequate 
lymph node samples were obtained in 157/171 (91,8%) TBFNA and 14/171(8,2%) TBFNA 
samples were inadequate.  
Results: Cytological findings consistent with sarcoidosis were found in 79/88 (89,77%) 
patients and 133/157 (84,71%) samples. Sensitivity of TBFNA cytology in sarcoidosis 
presenting as mediastinal/hilar lymphadenopathy was 78,7%, specificity 92,3%. 
Conclusions: Overall diagnostic accuracy of TBFNA cytology in the diagnosis of sarcoidosis 
was 86,2%, and cytological findings consistent with sarcoidosis were the only morphological 
diagnosis of sarcoidosis in 63,6% of patients.  
  
Key words: transbronchial, fine needle aspiration cytology, mediastinal/hilar 
lymphadenopathy, sarcoidosis, diagnostic accuracy 
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INTRODUCTION 
   
Sarcoidosis is a systemic granulomatous disease that primarily affects the lung and lymphatic 
systems of the body, most often mediastinal and hilar lymph nodes (1). Fine needle 
aspiration (FNA) is a simple, safe and cost-effective method; it can be performed in any body 
setting, with results usually available within a day. Transbronchial fine needle aspiration 
(TBFNA) is minimally invasive bronchoscopic procedure in the diagnosis and staging of 
mediastinal and/or hilar masses (2,3). The diagnosis of sarcoidosis is based on 
clinicoradiological information supported by morphological findings and transbronchial needle 
aspiration can demonstrate the elements of granulomatous inflammation in histological 
or/and cytological specimens.   
In the 1950s Brouet and Euler introduced transbronchial needle aspiration trough a 
rigid bronchoscope (4). Transbronchial needle aspiration during fiberoptic bronchoscopy was 
adapted by Wang et al. in 1978, avoiding more invasive surgical procedures, such as 
mediastinoscopy (2,5,6). The method was used for sampling of intraluminal lesions, but in the 
last two decades its primary indication has been to obtain material from mediastinal and/or 
hilar nodes in staging of lung carcinomas and differential diagnosis of reactive 
lymphadenopathy (2,3,4,7,8,9). Most authors report using a 19–gauge histology needle, 
which can provide both histologic and cytologic material (4,10). Specimens obtained with 
small needles of 20,22,26 gauges are suitable for cytological examination only (9,11,12). The 
presence of lymphocytes with or without other types of cells is an essential criterion of 
specimen adequacy in TBFNA of intrathoracal lymphadenopathy (12). The diagnostic value 
of transbronchial fine needle aspiration cytology in patients with sarcoidosis presenting as 
mediastinal/hilar lymphadenopathy has been investigated. 
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MATERIALS AND METHODS  
 
The patients with mediastinal and/or hilar lymphadenopathy by radiographic criteria 
who had a bronchoscopic TBFNA procedure performed between January 1999 and 
December 2003 in a single institution (University Hospital for Lung Diseases Jordanovac, 
Zagreb) were included in the study. 
All patients underwent bronchoscopy and TBFNA with 26-gauge needle for cytological 
analysis was performed. Punctures were repeated until macroscopically adequate material 
was obtained judged by brochoscopist and cytotechnologist. A cytopathologist was not 
present during the procedures and rapid on site evaluation was not performed. Direct smear 
technique was used for specimens preparation, specimens were air-dried and stained with 
May-Grünwald Giemsa. The needle was washed out and the solution sent for microscopical 
examination for the presence of acid-fast bacilli (AFB) and cultured on Löwenstein-Jensen 
medium.  
Specimens were inadequate if bronchial epithelial cells and macrophages, and/or sparse 
lymphocytes, comprised less than 30% of cell elements (12). The presency of lymphocytes 
with or without other types of cells is th essential criterion of specimen adequacy in TBFNA of 
intrathoracal lymphadenopathy (7,12,13). Specimens were considered adequate if there were 
more than 30% of lymphocytes as representative of lymph node sampling. Specimens were 
diagnostic for sarcoidosis if bronchial epithelial cells, erythrocytes, lymphoid cells with normal 
morphology and elements of granuloma were found. A cytological diagnosis of granuloma in 
TBFNA was established according to following criteria: the presence of epitheloid cells, 
scattered or in clusters, variable numbers of small lymphocytes, multinucleated giant cells, 
and no or minimal necrosis. Following the cytological examination specimens with minimal 
necrosis were restained with auramine and examined for the presence of AFB by 
fluorescence microscope.  
A final diagnosis of sarcoidosis was based upon: positive TBFNA cytology, negative AFB 
finding by fluorescence microscopy and negative growth of Mycobacterium tuberculosis in 
Lowenstein culture of TBFNA material, histopathological recognition of sarcoid granulomas in 
other bronchoscopic materials and clinical and radiologic findings consistent with sarcoidosis. 
 5 
Statistical methods:  
Sensitivity of TBFNA cytology was calculated as true positive (TP)/true positive + 
false negative (FN); specificity as true negative (TN)/true negative + false positive (FP); 
diagnostic accuracy as true positive + true negative/ true positive + true negative + false 
positive + false negative TP+TN/TP + TN + FP + FN; negative predictive value was 
calculated as true negative / true negative + false negative TN/TN + FN and positive 
predictive value as true positive/true positive + false positive TP/TP + FP (3,8). All TBFNA 
with cytological findings consistent with sarcoidosis, the diagnosis of which was confirmed by 
other procedures, were regarded as true positive. True negatives were adequate TBFNA 
specimens without cytological findings consistent with sarcoidosis in patients with a disease 
other than sarcoidosis. False negative were TBFNA specimens without specific cytological 
findings confirmed as sarcoidosis and false positive were TBFNA specimens with cytological 
findings consistent with sarcoidosis in diseases other than sarcoidosis.  
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RESULTS 
Among 116 patients with mediastinal and/or hilar lymphadenopathy, there were 70 
women and 46 men, mean age 46,  SD +/- 15 years. A diagnosis of sarcoidosis was 
established in 88 (75,9%) of patients, 57 woman and 31 men, mean age 43 years, SD +/- 13 
years.  
Adequate lymph node samples were obtained in 157/171 (91,8%) TBFNA and 14/171(8,2%) 
TBFNA samples were inadequate.    
The cytological findings are shown in Table 1. Findings consistent with sarcoidosis were 
present in 133/157 (84,7%) of TBFNA samples and 79/88 (89,8%) of patients with 
sarcoidosis proven otherwise.  
Multinucleated giant cells of Langhans type with epitheloid cells and variable numbers of 
lymphocytes with or without minimal necrosis, as the elements of granuloma, were found in 
63/88 (71,6%) of sarcoidosis patients and 104/157 (66,2%) of TBFNA samples (Figures 1 
and 2). Small groups or scattered epithelioid cells with lymphocytes, without multinucleated 
giant cells or necrosis were considered as findings consistent with sarcoidosis in 16/88 
(18,2%) patients and 29/157 (18,5%) of TBFNA samples (Figure 3). Elements of lymph node 
or lymph node hyperplasia were found in 9/88 (10,2%) of sarcoidosis patients and 24/157 
(15,3%) of TBFNA samples. These findings were non-specific and non-indicative of 
sarcoidosis, and were considered as negative adequate TBFNA samples. In 63,6% of our 
patients TBFNA cytology was the only morphological evidence of granulomatous 
inflammatory disease.  
Sensitivity of TBFNA cytology in sarcoidosis presenting as mediastinal/hilar 
lymphadenopathy was 78,7% and specificity 92,3%. The positive predictive value for 
sarcoidosis was 97,8% and negative predictive value 60%. Overall diagnostic accuracy of 
TBFNA cytology in the diagnosis of mediastinal/hilar sarcoidosis was 86,2%. 
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DISCUSSION 
Transbronchial fine needle aspiration is a minimally invasive bronchoscopic 
procedure, which is an effective, cost-saving method for the diagnosis and mediastinal 
staging of lung carcinoma, with many documented reports in the literature (2,5,6,14,15,16). 
Recently, new studies concerning the value of TBFNA in the diagnosis of sarcoidosis 
depending on the stage of disease, needle gauge and other factors have emerged 
(2,3,4,11,17).  
In our study a small 26-gauge needle  was used for TBFNA and material for 
cytological analysis only was obtained. Fine needle aspiration (FNA) in this location is more 
difficult to perform than FNA in many other sites, because the target is indirectly visualized by 
radiographic methods (12,18).  
Inadequate material was obtained in 8,2% TBFNA of sarcoidosis presenting as 
mediastinal/hilar lymphadenopathy. Proportions of inadequate material ranged from 7-26% in 
other reports, as shown in Table 2. (3,14,15,19,20). There were differences in number of 
patients, needle gauges, aspiration site, and whether the material was obtained for 
cytological and/or histological analysis. Routinely, a 22-gauge cytology needle was used for 
staging and 18 or 19-gauge histology needles were used predominantly for diagnostic 
purposes (19).  
Cytological findings consistent with sarcoidosis in our study were considered positive and 
specific for sarcoidosis. Positivity in mediastinal/hilar sarcoidosis in our report was 84,7% in 
TBFNA specimens and in 89,8% of patients, higher than positivity of TBFNA in previously 
reported studies, which varies from 42-72% (3,4,11,17). Trisolini and Wang have already 
suggested that the high density of granulomas in sarcoid lymph nodes was responsible for 
the high percentage of positive granuloma findings even in cytological samples (2,3). High 
positivity can also be partially explained by preparation technique of cytology specimens. 
Glass-to-glass direct smearing technique of needle content was used, with probably less 
negative influence on granuloma architecture and loss of cells then flush technique with 
cytocentrifugation, as previously reported by Trisolini et al. (3). However, the small diameter 
of the cytological needle used for TBFNA and glass-to-glass smearing technique, in our 
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opinion, can sometimes be responsible for distortion of multinucleated giant cells, with a 
negative effect on identification of multinucleated giant cells of Langhans type. 
In 63,6% of our patient TBFNA cytology was the only morphological evidence of 
granulomatous disease, Trisoloni at al. reported 62% (3). Lmphocytes with epithelioid cells 
scattered or in small clusters in TBFNA were not sufficient to diagnose a granuloma, but were 
also considered as specific findings consistent with sarcoidosis, forming about 25% of 
positive findings. Ceinkaya et al. reported tuberculosis as the most common cause of benign 
intrathoracic lymph node enlargement in Turkey (11). In our study, all TBFNA with epithelioid 
cells and without necrosis in patients with mediastinal/hilar lymphadenopathy were confirmed 
as specific for sarcoidosis by transbronchial lung biopsy, radiological and clinical findings and 
follow up.  
Sensitivity and specificity of TBFNA cytology of mediastinal/hilar lymphadenopathy in the 
diagnosis of sarcoidosis in our material were high, 78,7% and 92,3% respectively, due to the 
relatively low percentage of false negatives and small number of false positives, compared 
with results of Trisolini et al. (table 3). Predictably, positive predictive value for sarcoidosis 
was 97,8% and negative predictive value was lower, i.e. 60%. Trisolini et al. reported 
sensitivity and specificity of 69% and 91% respectively (3). In our study, sensitivity was 
slightly higher, 78,7%. Diagnostic accuracy of TBFNA cytology for sarcoidosis varies from 65-
76% in different studies, depending on needle size and number of patients involved (Table 
3.) (3,4,11,16,17). Diagnostic accuracy for 157 TBFNA samples in 88 patients with 
sarcoidosis presenting as mediastinal/hilar lymphadenopathy in our study was slightly higher, 
i.e. 86,2%, probably due to the high percantage of cytological findings consistent with 
sarcoidosis even in the absence of granuloma.  
The accuracy of TBFNA cytology in the diagnosis of mediastinal/hilar sarcoidosis is 
dependent on the needle gauge and the number of patients studied, as well as on the 
brochoscopist`s skill and the efficiency of the cytology laboratory. 
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Tables: 
Sarcoidosis 
patients (88)     TBFNA (157) Cytological findings 
No Percent No Percent 
Findings consistent with sarcoidosis 
- Elements of granuloma 
- Lymphocytes,  epithelioid cells 
79 
63 
16 
89,8 
71,6 
   18,2 
133 
104 
 29 
84,7 
66,2 
18,5 
Elements of lymph node or lymph node 
hyperplasia 
- Lymph nodes hyperplasia 
- Lymphocytes 
9 
3 
6 
10,2 
  3,4 
  6,8 
24 
 5 
19 
15,3 
 3,2 
12,1 
 
Table1. Cytological findings in 157 TBNA specimens sampled in 88 patients with sarcoidosis 
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Author Ref. Needle Supstrate 
No. 
patients 
Inadequate samples 
Trisolini 3 19 G 
Intrathoracic 
lymphadenopathy 
32 26% (cytology only) 
Haponik 14 22G 
Mediastinal mass, 
peribronchial lesion  
185 8,3-25,6% 
Hsu 15  21 G 
Intrathoracic 
lymphadenopathy, 
peribronchial lesion  
90 7-21%  
Patteli 19 22 G 
Intrathoracic 
lymphadenopathy 
183 20% 
Hermens   20 19 G 
Intrathoracic 
lymphadenopathy 106 21% 
 
Table 2. 
Inadequte samples of transbronchial needle aspirations in different studies depending on 
needle gauge, substrate and number of patients. 
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Author Ref. Needle  
No. 
patients 
Dg. accuracy Sensitivity Specificity 
Trisolini 3 19 G 32 72% 
69% cytology 
91% 
histology 
91% cytology  
and histology 
Pauli  4 18 G 152 72% / / 
Cetinkaya 11 22 G 60 
65-76% 
granulomas 
/ / 
Wang 16 18 G 25 72% / / 
Morales  17 19 G 30 53% / / 
 
Table 3.  
Diagnostic yield of transbronchial needle aspiration in the diagnosis of mediastinal/hilar 
sarcoidosis 
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Figures:  
Figure 1.  
Cluster of epithelioid cells and small lymphocytes in TBFNA smear of granuloma in 
sarcoidosis (May-Grunwald–Giemsa stain, x200)  
 
  
 
 
Figure 2. 
Multinucleated giant cell of Langhans type in TBFNA smear of granuloma in sarcoidosis 
(May-Grunwald–Giemsa stain, x200) 
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Figure 3. 
Small groups or scattered epithelioid cells with lymphocytes in TBFNA smear of lymph node 
in sarcoidosis (May-Grunwald–Giemsa stain, x200) 
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